Trials / Unknown
UnknownNCT00561301
Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 43 (estimated)
- Sponsor
- Cooperative Study Group A for Hematology · Network
- Sex
- All
- Age
- 15 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
\- To evaluate the feasibility of combination chemotherapies comprising of gemcitabine-dexamethasone-oxaliplatin for patients with refractory or relapsed malignant non-Hodgkin lymphoma (NHL)
Detailed description
\- The feasibility will be evaluated in terms of objective response rate, efficacy of stem cell collection, disease-free survival, and overall survival.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GemDOx | gemcitabine oxliplatin |
Timeline
- Start date
- 2006-11-01
- Completion
- 2009-10-01
- First posted
- 2007-11-20
- Last updated
- 2007-11-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00561301. Inclusion in this directory is not an endorsement.